Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2617 (LINC02617)

Target
LINC02617
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2617 (LINC02617) is an RNA gene classified as a long intergenic non-coding RNA. LINC02617 does not code for a protein; instead, it is part of a broad class of non-coding RNAs that function in the regulation of gene expression, chromatin remodeling, or as molecular scaffolds in various regulatory processes. While lincRNAs as a category are known to participate in transcriptional regulation, epigenetic modulation, and as components of signaling networks in diverse biological contexts, there is currently no direct evidence or established functional annotation for LINC02617 specifically. This gene does not appear to be a recognized therapeutic target, and there are no known drugs, biomarker applications, or safety concerns associated with it. The information available does not indicate that LINC02617 is considered a therapeutic target, receptor, enzyme, transporter, or has roles in human disease; thus, it is best classified according to its molecular family (lincRNA) but not as a therapeutic target. There may be confusion with LINC00261, a different lincRNA with known roles in cancer, but LINC02617 and LINC00261 are distinct entities. Because canonical biological functions or disease roles for LINC02617 are lacking, and no drugs or biomarkers are well established for it, it should be flagged as `is_incorrect: true` for most structured biological databases targeting validated protein or RNA targets.

Other names
ENST00000539009LINC02617
02

Mechanism of action

None known for LINC02617

03

Biological functions

Unknown for LINC02617; general functions of lincRNAs include regulation of gene expression at transcriptional, post-transcriptional, and epigenetic levels, as well as fine-tuning the expression of neighboring genes with tissue specificity.
04

Disease associations

Unknown for LINC02617; for other lincRNAs, common disease associations include cancer, neurodegenerative disease, inflammation, and cardiovascular disease, but no evidence currently links LINC02617 to a specific pathology.
05

Safety considerations

None reported for LINC02617
06

Interacting drugs

None known for LINC02617
07

Biomarkers

None known for LINC02617

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2617 (LINC02617).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2617 (LINC02617).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call